Chuck Ence - Jan 29, 2024 Form 4 Insider Report for RELMADA THERAPEUTICS, INC. (RLMD)

Role
CA and CO
Signature
/s/ Chuck Ence
Stock symbol
RLMD
Transactions as of
Jan 29, 2024
Transactions value $
$150,920
Form type
4
Date filed
1/31/2024, 06:28 PM
Previous filing
Dec 19, 2023
Next filing
May 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLMD Common Stock Purchase $39.4K +10.8K $3.65 10.8K Jan 29, 2024 Direct F1, F2
transaction RLMD Common Stock Purchase $56.1K +14.5K +134.26% $3.87 25.3K Jan 30, 2024 Direct F1, F3
transaction RLMD Common Stock Purchase $55.4K +13.7K +54.03% $4.05 39K Jan 31, 2024 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The number of securities reported represents an aggregate number of shares purchased in multiple open market transactions over a range of purchase prices. The price reported represents the weighted average price. The Reporting Person undertakes to provide to the staff of the SEC, the Issuer, or a stockholder of the Issuer, upon request, the number of shares purchased by the Reporting Person at each separate price within the range.
F2 Purchase prices range from $3.585 to $3.73 per share, inclusive.
F3 Purchase prices range from $3.755 to $3.99 per share, inclusive.
F4 Purchase prices range from $3.93 to $4.17 per share, inclusive.